AllPennyStocks.com Biotech Steals The Mid-Week Spotlight With Key Announcement

Biotech Steals The Mid-Week Spotlight With Key Announcement

Biotech Steals The Mid-Week Spotlight With Key Announcement By: Tomas Ronolski - AllPennyStocks.com News

Wednesday, June 11, 2025

A California-based biotech company stole the show on Wednesday after the company reported positive clinical data demonstrating that its second-generation vaccine technology produces much stronger antibody responses than its first-generation technology, according to a recent press release.

Traders wasted little time buying up shares of Vaxart Inc. (Nasdaq:VXRT) on Wednesday, pushing the small cap to close the session up at $0.5041/share (+28.30%).

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.


Copyright © 2025 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

A $1 Billion Crypto Deal Sends This Microcap Surging
Chilean Gold Developer Gains 15% on Final Permit Clearance
Chile Copper Explorer Gains 19% on 795m Porphyry Hit
Most Popular
{{ index + 1 }}


Back to Top